ProCE Banner Activity

Strategies to Maintain Adherence and Persistence to Oral Therapies in Early Breast Cancer

Clinical Thought

Read about barriers to adherence with oral therapies for early breast cancer, interventions to improve adherence, and available patient resources to promote medication persistence.

Released: April 13, 2023

Share

Faculty

Reshma Mahtani

Reshma Mahtani, DO

Chief of Breast Medical Oncology
Miami Cancer Center
Baptist Health South Florida
Miami, Florida

Provided by

Provided by Clinical Care Options, LLC.

ProCE Banner

Supporters

Supported by an educational grant from Lilly.

Lilly

Faculty Disclosure

Primary Author

Reshma Mahtani, DO

Chief of Breast Medical Oncology
Miami Cancer Center
Baptist Health South Florida
Miami, Florida

Reshma L. Mahtani, DO: consultant/advisor: Agendia, Amgen, AstraZeneca, Daiichi Sankyo, Eisai, Genentech, Hologic, Lilly, Merck, Novartis, Pfizer, Puma, SeaGen, Sermonix, Stemline.